%PDF-1.4
%
30 0 obj
<>
endobj
27 0 obj
<>
endobj
83 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-03-05T12:17:31Z
2024-03-28T14:15:57-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-28T14:15:57-07:00
application/pdf
Heather
2002-297.may
uuid:c7741594-1dd1-11b2-0a00-f408276d7200
uuid:c7741597-1dd1-11b2-0a00-b80000000000
endstream
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
31 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
97 0 obj
[101 0 R]
endobj
98 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 61 714.5293 Tm
[(4.)-875.1 (Szejnfeld )17.7 (VL, Monier)19.7 (-Faugere M-C, Bignar BJ, Ferraz MB,)]TJ
1.675 -1.25 Td
(Malluche HM. Systemic osteopenia and mineralization defect in)Tj
0 -1.25 TD
(patients with ankylosing spondylitis. J Rheumatol 1997;24:683-8.)Tj
-1.675 -1.25 Td
[(5.)-875.1 (W)39.8 (ill R, Palmer R, Ring F)79.7 (, Calin )54.8 (A. )54.8 (Ankylosing spondylitis is )]TJ
1.675 -1.25 Td
(associated with marked osteopenia of the lumbar spine and femoral)Tj
T*
(neck in patients with mobile spines and hips. Br J Rheumatol)Tj
0 Tc T*
(1989;28 Suppl 1:19.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(6.)-875.1 (Mitra D, Elvins DM, Speden DJ, Collins )54.8 (AJ. )17.7 (The prevalence of)]TJ
1.675 -1.25 Td
(vertebral fractures in mild ankylosing spondylitis and their )Tj
T*
[(relationship to bone mineral density)64.8 (. Rheumatology 2000;39:85-9.)]TJ
-1.675 -1.25 Td
[(7.)-875.1 (W)39.8 (ill R, Palmer R, Bhalla )54.8 (AK, Ring F)79.7 (, Calin )54.8 (A. Osteoporosis in)]TJ
1.675 -1.25 Td
[(early ankylosing spondylitis: )54.8 (A)-220.1 (primary pathological event? Lancet)]TJ
0 Tc 0 Tw T*
(1989;2:1483-5.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875.1 (Ralston SH, Urquhart GDK, Brzeski M, Sturrock RD. Prevalence)]TJ
1.675 -1.25 Td
(of vertebral compression fractures due to osteoporosis )Tj
T*
(in ankylosing spondylitis. BMJ 1990;300:563-5.)Tj
-1.675 -1.25 Td
[(9.)-875.1 (Cooper C, Carbone L, Michet C, )54.8 (Atkinson E, O\325Fallon )17.7 (W)91.9 (, Melton)]TJ
1.675 -1.25 Td
(L. Fracture risk in patients with ankylosing spondylitis \321 a )Tj
T*
[(population-based study)64.8 (. J Rheumatol 1994;21:1877-82.)]TJ
-2.175 -1.25 Td
[(10.)-875.1 (Donnelly S, Doyle DV)128.8 (, Denton )54.8 (A, Rolfe I, McCloskey EV)128.8 (, Spector)]TJ
2.175 -1.25 Td
(TD. Bone mineral density and vertebral compression fracture rates)Tj
T*
[(in ankylosing spondylitis. )54.8 (Ann Rheum Dis 1994;53:1)36.8 (17-21.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Hunter )17.7 (T)74 (, Dubo H. Spinal fractures complicating ankylosing)]TJ
2.1381 -1.25 Td
[(spondylitis. )54.8 (Arthritis Rheum 1983;26:751-9.)]TJ
30.825 28.75 Td
[(12.)-875.1 (Hodgson SF)79.7 (, )17.7 (W)79.9 (atts NB, Bilezikian JP)110.7 (, et al. )54.8 (American )54.9 (Association)]TJ
2.175 -1.25 Td
(of Clinical Endocrinologists 2001 medical guidelines for clinical)Tj
T*
(practice for the prevention and management of postmenopausal)Tj
T*
(osteoporosis. Endocr Pract 2001;7:293-312)Tj
-2.175 -1.25 Td
[(13.)-875.1 (Osteoporosis \321 clinical guidelines for prevention and treatment.)]TJ
0 Tc 2.175 -1.25 Td
(Royal College of Physicians of London, 1999. ISBN 1860160794.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(14.)-875.1 (Recommendations for the prevention and treatment of )]TJ
2.175 -1.25 Td
[(glucocorticoid-induced osteoporosis. )54.8 (American College of)]TJ
T*
[(Rheumatology )17.7 (T)69.9 (ask Force on Osteoporosis Guidelines. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1996;39:1791-801.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(15.)-875.1 (Sewell K, Schein JR. Osteoporosis therapies for rheumatoid)]TJ
2.175 -1.25 Td
[(arthritis patients: minimizing gastrointestinal side ef)17.7 (fects. Semin)]TJ
T*
(Arthritis Rheum 2001;30:288-97. )Tj
-2.175 -1.25 Td
[(16.)-875.1 (Devogelaer J-P)110.7 (, Dufour J, Huaux J, Nagant de Deuxchaisnes C.)]TJ
2.175 -1.25 Td
(Appendicular and spinal bone mass in ankylosing spondylitis. Clin)Tj
T*
(Rheumatol 1984;3:105.)Tj
-2.175 -1.25 Td
[(17.)-875.1 (Singh )54.8 (A, Bronson )17.7 (W)91.9 (,)-0.1 ( )17.7 (W)79.9 (alker SE, )54.8 (Allen SH. Relative value of)]TJ
2.175 -1.25 Td
(femoral and lumbar bone mineral density assessments in patients)Tj
T*
(with ankylosing spondylitis. South Med J 1995;88:939-43.)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Bronson )17.7 (WD, )17.7 (W)79.9 (alker SE, Hillman LS, Keisler D, Hoyt )17.7 (T)74.1 (,)-0.1 ( )54.8 (Allen)]TJ
2.175 -1.25 Td
(SH. Bone mineral density and biochemical markers of bone )Tj
T*
(metabolism in ankylosing spondylitis. J Rheumatol 1998;)Tj
0 Tc 0 Tw T*
(25:929-35.)Tj
ET
0 0 0 0 scn
424 777 133 -27 re
f*
BT
0 0 0 1 scn
/T1_1 1 Tf
-0.00011 Tc 20.37 0 0 21 460.9631 760.6089 Tm
(\002\003\003\002\004\002\005\006\004#)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:4)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(782)Tj
ET
0 0 0 0 scn
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
35 0 obj
<>
endobj
34 0 obj
<>
endobj
41 0 obj
<>
endobj
74 0 obj
<>
endobj
88 0 obj
<>
endobj
33 0 obj
<>
endobj
66 0 obj
<>stream
HUyPS\,FE&u,H_[u\p{fY"D !!Ad YD"⊈{wmX_fJ_M?f7sw91^^[Kb&Ex$r~
+Y8;ێCr9-r 8a:ZisLƭڦSǪY.CNaS}ǧkeDItB0cѧ˗}ɘ].EEUrX*m%(whul]\(l2Ip"1rۊzkҪZuD,Mi4]:#2-#*jk2R)4[gpe=Ytpl
m֗hzkwxXC9I_q{uӕπ Us
TK2wyѨr3rLLWJ_=vC?'̀vu1B[d|BpB{@"h6#-栏@/"4PxD{}O+j:HH.xRSrn`FSW" "c▆sw+KL~uw!3%3w ogTNu$Qw@:3JF8bRt@R_VPd[9Uzmfy@+/p!\M\vL]>4P2Ů`p$Xw*zT8TrIJP
'szrk'ݹ@$w5`pJND˳cg
@%G&osiVA~3?Pcer*9}ο2Ը s6yzFMRw|a{*FUQѧ(uUi9Z}zs0]K]BhYqDoGxΔELБmۂvHQÚc:{OG_FU\`x? JU0v_l-/%Ğ
h-B#If@4YXg=uOl^D۠y;|{3-`Cj{N˽`#9CSm?ꀁ=[6!0l9ɺ08h&X''=FFmN^x(|HPr|2 `i3gC@8hXp.Ut!URH#6pg?a搚K
6S lE{+7sYIU~KAM^Jۣ)<瓋.YCPymc-k~J)>+;Y$~r֩V:7SطEUD$y>ߌ`K]l,YqPQXqToL5Q;o}8u;/;vjro#|kfj
6BpkVt'">#¶ӆªyVoX1ZRdOa5rz6C=5j<DxJ?) ud
.drnh$0D&sA.Yg(ՕFW4;>F^,&G*9^\B8V n1
@Be6 OAaڹ>lA $_gbi#m#}^YouOƦj}겾WUyى*謔|cSqH~wltSۢ1V2Ly_կ0 -KYw>X]搼KOmn|N-Cnۍň
cxA v
M$|*vD&p-!JI0
.呚OKtHOP~tvb#&wSHg_ ԛ
_tϺH:
ll;gm' 2{y+n@=˅qFu9"h 9/4{`I*[@>20J-t8>X
l|aџ;cP*Z}ڴHoYJu